Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 58

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy in the Treatment of Patients of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Inclusion Criteria: Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

DFC AMG 20110203 GALACTIC-HF-A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

Key Inclusion Criteria: •Male or female, ≥ 18 to ≤ 85 years •History of chronic HF (defined as requiring treatment for HF for a minimum of 30 days...

Daniel Eisenberg, M.D.
  • PMI Cardiology
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

Phase I Study of Intratumoral CAVATAK (TM) (Coxsackievirus A21) and Pembrolizumab in Subjects with Advanced Melanoma

This study will employ a phase Ib design using the established dose of CAVATAK with pembrolizumab in subjects with advanced melanoma for whom...

Steven O'Day, M.D.
  • California Research
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

A Prospective, Randomized, Blinded, Placebo-Controlled, Phase IIB Trial Of An Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine vs. Unloaded YCWP + DC in Stage III and Stage IV (Resected) Melanoma To Prevent Recurrence

The majority of melanoma vaccines tested to date have been antigen-specific vaccines targeting melanoma-specific or associated antigens and...

Steven O'Day, M.D.
  • California Research
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

A Phase I/II Study to assess the Safety and Efficacy of MK-3475 in Combination with Trametinib and Dabrafenib in Subjects with Advanced Melanoma

This is a 5-part dose-finding and preliminary efficacy study of pembrolizumab (Pembro) + dabrafenib (D) + trametinib (T) for participants with...

Steven O'Day, M.D.
  • California Research
  • John Wayne Cancer Institute (JWCI)
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)
« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 58